Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy of the combined treatment (methimazole plus selenium) in the
control of hyperthyroidism as compared to methimazole alone in 30 Graves' disease (GD)
untreated patients.